These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 19164493)
1. The uses and outcomes of quetiapine in depressive and bipolar mood disorders in clinical practice. Shajahan P; Taylor M J Psychopharmacol; 2010 Apr; 24(4):565-72. PubMed ID: 19164493 [TBL] [Abstract][Full Text] [Related]
2. Combination of mood stabilizers with quetiapine for treatment of acute bipolar disorder: an open label study. Bahk WM; Yoon BH; Lee KU; Chae JH Hum Psychopharmacol; 2004 Apr; 19(3):181-5. PubMed ID: 15079852 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep. Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180 [TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania. McElroy SL; Martens BE; Winstanley EL; Creech R; Malhotra S; Keck PE J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274 [TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of adjunctive quetiapine for bipolar mania. Pae CU; Kim TS; Kim JJ; Lee SJ; Lee CU; Lee C; Paik IH Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):763-6. PubMed ID: 15951090 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH; J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366 [TBL] [Abstract][Full Text] [Related]
8. Night locomotor activity and quality of sleep in quetiapine-treated patients with depression. Todder D; Caliskan S; Baune BT J Clin Psychopharmacol; 2006 Dec; 26(6):638-42. PubMed ID: 17110822 [TBL] [Abstract][Full Text] [Related]
9. Mood stabilization in the treatment of bipolar disorder: focus on quetiapine. Vieta E Hum Psychopharmacol; 2005 Jun; 20(4):225-36. PubMed ID: 15880391 [TBL] [Abstract][Full Text] [Related]
10. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania. Sussman N; Mullen J; Paulsson B; Vågerö M J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR; J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817 [TBL] [Abstract][Full Text] [Related]
12. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E; Mullen J; Brecher M; Paulsson B; Jones M Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892 [TBL] [Abstract][Full Text] [Related]
13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms. McIntyre RS; Konarski JZ; Jones M; Paulsson B J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. Langosch JM; Drieling T; Biedermann NC; Born C; Sasse J; Bauer H; Walden J; Bauer M; Grunze H J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216 [TBL] [Abstract][Full Text] [Related]
16. Quetiapine dosage in bipolar disorder episodes and mixed states. Khazaal Y; Tapparel S; Chatton A; Rothen S; Preisig M; Zullino D Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):727-30. PubMed ID: 17291654 [TBL] [Abstract][Full Text] [Related]
17. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM). Vieta E; Angst J; Reed C; Bertsch J; Haro JM; J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690 [TBL] [Abstract][Full Text] [Related]
18. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine. Buckley PF; Paulsson B; Brecher M J Affect Disord; 2007; 100 Suppl 1():S33-43. PubMed ID: 17376537 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Sokolski KN; Denson TF Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study. Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W; Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]